Insights

Target Undruggables Mitotherapeutix focuses on RNA chemistry and siRNA approaches to target previously undruggable disease targets, presenting a clear opportunity for collaborations or contract work in novel target engagement, preclinical validation, and RNA-based therapeutics development services.

Early-Stage Agility With a small team and early-stage funding signals (revenue in the low to mid‑range), there is potential for scalable partnerships, pilot projects, and low-commitment collaborations that can demonstrate value quickly and expand as capabilities mature.

RNA Tech Enablement Capitalize on their RNA chemistry focus by proposing specialized CRO/consulting services in siRNA design, delivery, and optimization, as well as assistance with regulatory-readiness for RNA therapies.

Strategic Partnerships Aligned with larger players in the RNA therapeutics space (e.g., the broader competitive landscape), Mitotherapeutix could benefit from joint-venture or milestone-based partnerships that leverage their niche expertise while providing scalable impact.

Brand & Reach Given their current tech stack and web presence, there is an opportunity to support brand development, content marketing, and thought leadership programs to attract collaborators, investors, and talent, accelerating deal flow.

Similar companies to Mitotherapeutix

Mitotherapeutix Tech Stack

Mitotherapeutix uses 8 technology products and services including RSS, WordPress, jQuery Migrate, and more. Explore Mitotherapeutix's tech stack below.

  • RSS
    Content Management System
  • Content Management System
  • jQuery Migrate
    Javascript Libraries
  • WordPress Block Editor
    Page Builders
  • Priority Hints
    Performance
  • Hostgator
    Web Hosting
  • Apache
    Web Servers
  • Nginx
    Web Servers

Mitotherapeutix's Email Address Formats

Mitotherapeutix uses at least 1 email format:
Mitotherapeutix Email FormatsExamplePercentage
FLast@mitotherapeutix.comJDoe@mitotherapeutix.com
100%

Frequently Asked Questions

What is Mitotherapeutix's official website and social media links?

Minus sign iconPlus sign icon
Mitotherapeutix's official website is mitotherapeutix.com and has social profiles on LinkedIn.

How much revenue does Mitotherapeutix generate?

Minus sign iconPlus sign icon
As of November 2026, Mitotherapeutix's annual revenue is estimated to be $1M - $10M.

What is Mitotherapeutix's NAICS code?

Minus sign iconPlus sign icon
Mitotherapeutix's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Mitotherapeutix have currently?

Minus sign iconPlus sign icon
As of November 2026, Mitotherapeutix has approximately 6 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: T. M., Chief Scientific Officer: C. A. and Co-Founder: R. H. Explore Mitotherapeutix's employee directory with LeadIQ.

What industry does Mitotherapeutix belong to?

Minus sign iconPlus sign icon
Mitotherapeutix operates in the Research Services industry.

What technology does Mitotherapeutix use?

Minus sign iconPlus sign icon
Mitotherapeutix's tech stack includes RSS, WordPress, jQuery Migrate, WordPress Block Editor, Priority Hints, Hostgator, Apache and Nginx.

What is Mitotherapeutix's email format?

Minus sign iconPlus sign icon
Mitotherapeutix's email format typically follows the pattern of FLast@mitotherapeutix.com. Find more Mitotherapeutix email formats with LeadIQ.

When was Mitotherapeutix founded?

Minus sign iconPlus sign icon
Mitotherapeutix was founded in 2014.
Mitotherapeutix logo

Mitotherapeutix

Research ServicesConnecticut, United States2-10 Employees

Mitotherapeutix operates in the research services sector, concentrating on how RNA chemistry can inform the development of new therapeutics. The company focuses on siRNA-based approaches intended to address disease targets that are difficult to drug using traditional modalities.

Based in Farmington, Connecticut, it is a small organization, suggesting a specialized, early-stage focus within the RNA therapeutics space. The work positions Mitotherapeutix among entities supporting the discovery and development of RNA-based medicines, potentially serving research teams and pharmaceutical collaborators seeking to tackle undruggable targets.

Section iconCompany Overview

NAICS Code
5417 - Scientific Research and Development Services
Founded
2014
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Mitotherapeutix's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.